Clinical Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. May 15, 2003; 9(5): 1090-1093
Published online May 15, 2003. doi: 10.3748/wjg.v9.i5.1090
Figure 3
Figure 3 ESL using Speedband, Superview multiple band ligator (Boston Scientific Co. , Watertown, MA) and sclero-therapy needle. (A) EVL at least 5 cm or more proximal to gastroesopahgeal junction, (B) sclerotherapy 2 to 3 cm proximal to gastroesophageal junction on the same varix, (C) EVL on the injection site (arrow) and (D) proximal (large arrow) and distal (small arrow) EVL on the same varix.